MedPath
HSA Approval

APO-CEPHALEX TABLET 250 mg

SIN08382P

APO-CEPHALEX TABLET 250 mg

APO-CEPHALEX TABLET 250 mg

October 12, 1995

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J01DB01

cefalexin

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC

Active Ingredients

CEPHALEXIN MONOHYDRATE EQV CEPHALEXIN

250 mg

Cephalexin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-CEPHALEX TABLET 250 mg - HSA Approval | MedPath